U.S., May 12 -- ClinicalTrials.gov registry received information related to the study (NCT07577856) titled 'A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis' on May 05.
Brief Summary: The purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to guselkumab at Week 48 in participants with moderately to severely active ulcerative colitis (UC, a chronic disease of the large intestine in which the lining of the colon becomes inflamed and develops ulcers).
Study Start Date: May 29
Study Type: INTERVENTIONAL
Condition:
Colitis, Ulcerative
Intervention:
DRUG: JNJ-78934804
JNJ-78934804 will be administered subcutaneously.
DRUG: Guselkuma...